[1]
VS, S. et al. 2025. FORMULATION AND EVALUATION OF DRY POWDER INHALABLE NANOPARTICLES FOR THE TREATMENT OF COVID-19. International Journal of Applied Pharmaceutics. 17, 5 (Sep. 2025), 227–237. DOI:https://doi.org/10.22159/ijap.2025v17i5.54859.